Taisuke Nabeshima

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

UTILITY OF AN ELEVATED PLUS MAZE FOR THE EVALUATION OF NOOTROPICS, SCOPOLAMINE AND ELECTRO CONVULSIVE SHOCK

Jin Itoh, Taisuke Nabeshima, Tsutomu Kameyama · 1990 · 30 citations

Life Sciences, Behavioral Sciences, Neuroscience +5

High Prevalence of the <i>SCN5A</i> E1784K Mutation in School Children With Long QT Syndrome Living on the Okinawa Islands

Kazuhiro Takahashi, Wataru Shimizu, Akira Miyake et al. · Circulation Journal · 2014 · 23 citations · Full text

Medicine, Genetics, Molecular Genetics +17

A novel de novo calmodulin mutation in a 6-year-old boy who experienced an aborted cardiac arrest

Kazuhiro Takahashi, Taisuke Ishikawa, Naomasa Makita et al. · HeartRhythm Case Reports · 2016 · 23 citations · Full text

Medicine, Cardiology, Pediatrics +17

Efficacy of SubcutAneous implantable cardioVErter-defibrillators in ≤18 year-old CHILDREN: SAVE-CHILDREN registry

Hitoshi Mori, Naokata Sumitomo, Kenta Tsutsui et al. · International Journal of Cardiology · 2022 · 16 citations

Medicine, Cardiology, Pediatrics +11